rAAV encoding CFTR gene therapy (Catholic University of Leuven)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamerAAV encoding CFTR gene therapy (Catholic University of Leuven)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKu Leuven
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A